4.5 Interaction with other medicinal products and other forms of interaction  
 No interaction studies have been performed.   
 Androgen deprivation therapy (ADT) and other therapies targeting the androgen pathway, such as androgen receptor antagonists, may result in changes in uptake of piflufolastat (
18F) in prostate cancer. The effect of these therapies on performance of piflufolastat (18F) PET has not been established.   
 Chronic treatment with diuretics does not seem to have any interference with piflufolastat (
18F) for interpretation of images.  
 